O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway
Main Authors: | Øyvind Molberg, Sella A Provan, Karoline Lerang, Cathrine Brunborg, Hilde Haukeland, Sigrid R Moe, Torild Garen, Antonela Botea, Anniken Orre, Heidi Øvreås, Thea Bøe, Gro Å Wivestad, Nenad Damjanic |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-03-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
S09.2 Gender differences in trends of incidence in systemic lupus erythematosus in Norway; estimates from a population-based cohort
by: T Garen, et al.
Published: (2022-10-01) -
Long-Term Outcome in Systemic Lupus Erythematosus; Knowledge from Population-Based Cohorts
by: Sigrid Reppe Moe, et al.
Published: (2021-09-01) -
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
by: Henriette Didriksen, et al.
Published: (2022-09-01) -
The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
by: Youkhana Youkhana, et al.
Published: (2023-07-01) -
Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
by: Jens Vikse, et al.
Published: (2023-09-01)